RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Clinical trials for RELAPSED/REFRACTORY AUTOIMMUNE DISEASES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY AUTOIMMUNE DISEASES trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY AUTOIMMUNE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to tame stubborn autoimmune diseases
Disease control Not yet recruitingThis early study tests an experimental drug called STR-P005 in people with autoimmune diseases that have come back or not improved with standard treatments. The drug is given through an IV in multiple doses. The main goal is to check safety and see how the body handles the drug. …
Matched conditions: RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Phase: NA • Sponsor: Starna Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug STR-P005 aims to tame stubborn autoimmune diseases
Disease control Not yet recruitingThis early study tests a new drug called STR-P005 in 18 people with autoimmune diseases that have not responded to standard treatments. The main goal is to check safety and find the best dose. Participants receive the drug by infusion in different schedules, and researchers will …
Matched conditions: RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC